Hello Reuben
There is information that the EU commission will extend 207/2012/eIFU for medical APPs (including those intended to be used by laypersons) but will maintain (for the time being) the current limitations on device type (implants, implant asseccories, fixed medical devices, and medical device software).
Considering the long-lasting experience with eIFU for medical devices - the FDA regulation for eIFU is 18 years in effect, the EU regulation 9 years - as well as the position of other regulatory authorities (FDA, Health Canada, TGA, Anvisa, SFDA) it is unclear why the EU commission maintains the restrictions for the EU.
And you are right, with MDR taking effect, device manufacturers with devices
used in the complete EU market will have to provide their IFUs in the 23 EU languages. With paper IFU this will lead to even more unnecessary paper, which has to be produced, transported and also discarded or recycled.
With regards,
Hans
------------------------------
Hans Strobel
www.dokspot.io------------------------------
Original Message:
Sent: 24-Mar-2021 16:33
From: Reuben Lidster
Subject: eIFU
Hello Hans,
Thank you for your post. I/we appreciate the information. Above though you state, "EU Reg 207/2012 (eIFU for Medical Devices) might soon be expanded to also cover IVD devices." Yet do you know of any new plans to open up EU eIFU product labeling, beyond 'implantables and fixed installed medical devices'? With EU MDR approaching, and the added IFU language requirements, some IFUs will potentially double in size. As you know, eIFUs are searchable, with expandable text (and don't get lost, torn or smudged) - and those are just some of the clinical advantages (not to mention the multiple environmental ones). This is why I'm hoping for more EU acceptability of eIFUs (as tends to be the case with definitely not all, but a lot of the rest of the world these days). However, I've noticed other RAPS discussion threads where EU Class IIa devices are getting eIFUs, apparently for the EU Market. I would not consider EU Class IIa devices to cover implantables and these don't sound like fixed installed medical devices either. This is why I am wondering if a wider application for EU eIFUs has been accepted for some (beyond implantables and fixed installed medical devices), or maybe it is just understood (and least by some) that an EU eIFU acceptance expansion is coming soon (although -for the record- I have no proof of one)? Thus, if you have any additional insights here, please let me know.
Thanks in advance!
------------------------------
Reuben Lidster
Regulatory Affairs Specialist
Bloomington IN
United States
Original Message:
Sent: 20-Mar-2021 10:26
From: Hans Strobel
Subject: eIFU
Hello
For the US consider Section 206 of the Medical Device User Fee and Modernization Act for the regulatory part. For QA, 21 CFR Part 11 and also ISO 13485 Sections 4.1.6 and 7.5.6. should be considered.
For the EU check MEDDEV 2.14/3 rev 1 from 2007. This is a guidance document. Also, consider EU Reg 2017/746 (IVDR) Chapter III, Article 20.1. For QA consider ISO 13485 Sections 4.1.6 and 7.5.6.
As there currently is no EU regulation for eIFU for IVD devices, the EU Reg 207/2012 (eIFU for Medical Devices) might soon be expanded to also cover IVD devices. I would therefore recommend building your eIFU system so that it meets the requirements of this regulation.
Best,
Hans
------------------------------
Hans Strobel
www.dokspot.io
Original Message:
Sent: 19-Mar-2021 10:34
From: Anonymous Member
Subject: eIFU
This message was posted by a user wishing to remain anonymous
Hello Everyone,
We are currently working on providing eIFUs with our IVD kits in the US and EU, and was wanting to seek advice from the discussion forum on what guidance documents should I be referring to for this.
Thanks in advance for any advice on this!